A Study of LY3214996 in Healthy Participants

NCT04033341 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3214996
DRUG: [14C]-LY3214996

Sponsor

Eli Lilly and Company